Purchases and Sales Made in Q4 2021 in Cyclerion Therapeutics, Inc. (CYCN)
This table provides information about the institutional ownership of Cyclerion Therapeutics, Inc. (CYCN) during Q4 2021. The information is specifically focused on institutions that hold shares of Cyclerion Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2022
Q4 2021
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-91.3KClosed |
$142K - $273K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-126K- 19.5% |
$197K - $378K
|
521K
$1.84M
|
|
|
Feb 14, 2022
Q4 2021
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-136K- 49.88% |
$212K - $406K
|
137K
$481K
|
|
|
Feb 14, 2022
Q4 2021
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-253K- 64.78% |
$395K - $756K
|
138K
$484K
|
|
|
Feb 14, 2022
Q4 2021
|
Eco R1 Capital, LLC
San Francisco, CA |
SELL
|
- |
-1.61MClosed |
$2.51M - $4.8M
|
0
$0
|